ATE322162T1 - Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen - Google Patents

Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen

Info

Publication number
ATE322162T1
ATE322162T1 AT01995177T AT01995177T ATE322162T1 AT E322162 T1 ATE322162 T1 AT E322162T1 AT 01995177 T AT01995177 T AT 01995177T AT 01995177 T AT01995177 T AT 01995177T AT E322162 T1 ATE322162 T1 AT E322162T1
Authority
AT
Austria
Prior art keywords
photosensitiser
inactivation
storage solution
biological contaminants
containing storage
Prior art date
Application number
AT01995177T
Other languages
English (en)
Inventor
Laura Mcburney
Raymond P Goodrich Jr
Original Assignee
Gambro Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Inc filed Critical Gambro Inc
Application granted granted Critical
Publication of ATE322162T1 publication Critical patent/ATE322162T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/124—Disinfecting agents, e.g. antimicrobials
    • A61L2103/05—

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01995177T 2000-11-28 2001-11-21 Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen ATE322162T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/725,426 US6548241B1 (en) 2000-11-28 2000-11-28 Storage solution containing photosensitizer for inactivation of biological contaminants

Publications (1)

Publication Number Publication Date
ATE322162T1 true ATE322162T1 (de) 2006-04-15

Family

ID=24914504

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01995177T ATE322162T1 (de) 2000-11-28 2001-11-21 Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen

Country Status (8)

Country Link
US (2) US6548241B1 (de)
EP (1) EP1345491B1 (de)
JP (1) JP4473508B2 (de)
AT (1) ATE322162T1 (de)
AU (1) AU2002225687A1 (de)
CA (1) CA2397862C (de)
DE (1) DE60118604T2 (de)
WO (1) WO2002043485A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099170A1 (en) * 1998-07-21 2007-05-03 Navigant Biotechnologies, Inc. Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US7094378B1 (en) * 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) * 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6969367B2 (en) * 2000-02-02 2005-11-29 Xepmed, Inc. Extracorporeal pathogen reduction system
US7470245B2 (en) * 2000-02-02 2008-12-30 Xepmed, Inc. Extracorporeal pathogen reduction system
US6936413B1 (en) * 2001-12-05 2005-08-30 Baxter International Inc. Methods and systems for preparing blood products
US7183045B2 (en) * 2002-04-24 2007-02-27 Gambro Inc. Removal of adenine during a pathogen reduction process in whole blood or red blood cell by dilution
EP1635638A1 (de) * 2003-06-20 2006-03-22 Pall Corporation Verarbeitung von plättchen-enthaltenden biologischen flüssigkeiten
US20070102858A1 (en) * 2005-11-07 2007-05-10 Navigant Biotechnologies, Inc. Clamps and methods for displacing fluid from portions of fluid containers
CA2629340A1 (en) * 2005-12-06 2007-06-14 Navigant Biotechnologies, Llc Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
AU2012233032B2 (en) * 2006-01-27 2015-07-16 Terumo Bct Biotechnologies, Llc Methods and compositions for the production of high concentration alloxazine solutions
CA2849648A1 (en) * 2006-01-27 2007-08-09 Terumo Bct Biotechnologies, Llc Method for inactivating pathogens in a biological fluid
US20080234622A1 (en) * 2007-03-20 2008-09-25 Gambro Bct Inc. Methods and Systems for Preparing Blood Products
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
US20100190676A1 (en) * 2008-07-22 2010-07-29 Ecolab Inc. Composition for enhanced removal of blood soils
US20100081985A1 (en) * 2008-10-01 2010-04-01 Caridianbct, Inc. Platelet Additive Solution For Leukoreducing White Blood Cells In Apheresed Platelets
US9732324B2 (en) 2008-10-23 2017-08-15 Cornell University Anti-viral method
US8715920B2 (en) 2010-07-27 2014-05-06 Biovec Transfusion, Llc Composition for preserving platelets during photosensitization
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US11864553B2 (en) 2009-10-23 2024-01-09 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
EP2694131B1 (de) 2011-04-07 2019-08-28 Fenwal, Inc. Automatisierte verfahren und systeme zur bereitstellung von thrombozytenkonzentraten mit reduziertem restplasmavolumen und medien zur lagerung solcher thrombozytenkonzentrate
WO2013006631A1 (en) * 2011-07-05 2013-01-10 New Health Sciences, Inc. A system for extended storage of red blood cells and methods of use
WO2013106605A1 (en) 2012-01-11 2013-07-18 Terumo Bct Biotechnologies, Llc Slidable clamp for port isolation
WO2014028688A1 (en) * 2012-08-16 2014-02-20 Erickson Dirk Jerome Exsanguination preventing device
CN110822822B (zh) 2014-06-09 2021-08-24 泰尔茂比司特公司 冻干法
EP4670504A2 (de) 2015-03-10 2025-12-31 Hemanext Inc. Einweg-kits zur sauerstoffreduktion, vorrichtungen und verfahren zur verwendung davon
CA2983295C (en) 2015-04-23 2024-02-13 New Health Sciences, Inc. Anaerobic blood storage containers
JP6895426B2 (ja) 2016-03-23 2021-06-30 テルモ株式会社 光照射装置
IL273433B2 (en) * 2017-09-20 2025-01-01 Cerus Corp Compositions and methods for inactivating platelet pathogens

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786014A (en) 1952-09-10 1957-03-19 James L Tullis Platelet preservation
US3629071A (en) 1970-02-10 1971-12-21 Upjohn Co Storage-stable hemostatic transfusion suspensions of blood platelets, glucose, magnesium chloride and certain prostaglandins
US3874384A (en) 1971-11-01 1975-04-01 American Hospital Supply Corp Improved blood storage unit and method of storing blood
DE2532183C3 (de) 1975-07-18 1982-03-04 Behringwerke Ag, 3550 Marburg Polyionische isotonische Salzlösung zur Konservierung von Erythrozyten oder zur Perfusion und zur Konservierung von zur Transplantion bestimmter Organen
US4112070A (en) 1977-06-08 1978-09-05 Research Corporation Blood preservation system
GB2034463B (en) 1978-11-11 1983-03-30 Ryan W Plaetelet reference control
US4267269A (en) 1980-02-05 1981-05-12 Baxter Travenol Laboratories, Inc. Red cell storage solution
US4568542A (en) 1981-06-09 1986-02-04 Lee Biomolecular Research Laboratories, Inc. Vaccine compositions
US4390619A (en) 1981-09-28 1983-06-28 James Clifford Haight Leukocyte or platelet storage using ion-exchange resins
JPS5862333A (ja) * 1981-10-09 1983-04-13 Mazda Motor Corp エンジンのアイドル回転制御装置
US4432750A (en) 1981-12-02 1984-02-21 Baxter Travenol Laboratories, Inc. Additive sterol solution and method for preserving normal red cell morphology in whole blood during storage
DE3225408A1 (de) 1982-07-07 1984-01-12 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Waessrige loesung zum suspendieren und lagern von zellen, insbesondere erythrozyten
CA1216518A (en) 1982-11-01 1987-01-13 Gail A. Rock Plasma-free medium for platelet storage
US4748120A (en) 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4609372A (en) 1983-10-13 1986-09-02 Miles Laboratories, Inc. Heat sterilizable storage solution for red blood cells
GB8328495D0 (en) 1983-10-25 1983-11-23 Wellcome Found Pharmacologically active ketones
US4828976A (en) 1983-12-29 1989-05-09 Thomas Jefferson University Glucose free media for storing blood platelets
US4992363A (en) 1983-11-09 1991-02-12 Thomas Jefferson University Method for preparing glucose free media for storing blood platelets
CA1244774A (en) * 1983-11-09 1988-11-15 Thomas Jefferson University Medium for storing blood platelets
US4585735A (en) 1984-07-19 1986-04-29 American National Red Cross Prolonged storage of red blood cells
JPS61275228A (ja) 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
US4704352A (en) 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
US4675185A (en) 1985-12-06 1987-06-23 Baxter Travenol Laboratories, Inc. Solution for stabilizing red blood cells during storage
US5281392A (en) 1986-03-10 1994-01-25 Rubinstein Alan I Method for disinfecting red blood cells, blood products, and corneas
US4961928A (en) 1986-03-19 1990-10-09 American Red Cross Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets
US4695460A (en) * 1986-03-19 1987-09-22 American Red Cross Synthetic, plasma-free, transfusible platelet storage medium
US5248506A (en) 1986-03-19 1993-09-28 American National Red Cross Synthetic, plasma-free, transfusible storage medium for red blood cells and platelets
US4769318A (en) 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US4726949A (en) 1986-08-26 1988-02-23 Baxter Travenol Laboratories, Inc. Irradiation of blood products
DE3805459A1 (de) 1988-02-22 1989-08-31 Biotest Pharma Gmbh Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl.
US4994367A (en) 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
US5211960A (en) 1988-11-29 1993-05-18 Scripps Clinic And Research Foundation Stabilization of leukocytes
US5041078A (en) 1989-03-06 1991-08-20 Baylor Research Foundation, A Nonprofit Corporation Of The State Of Texas Photodynamic viral deactivation with sapphyrins
US4999375A (en) 1989-04-11 1991-03-12 Hoffmann-La Roche Inc. Psoralen reagent compositions for extracorporeal treatment of blood
US4925665A (en) 1989-06-22 1990-05-15 Thomas Jefferson University Glucose free primary anticoagulant for blood containing citrate ions
CA2067134C (en) 1989-10-06 2001-02-13 Harold T. Meryman Procedure for storing red cells with prolonged maintenance of cellular concentrations of atp and 2,3 dpg
US5236716A (en) 1990-02-12 1993-08-17 Miles Inc. Platelets concentrate with low white blood cells content
US5147776A (en) 1990-02-26 1992-09-15 University Of Iowa Research Foundation Use of 2,5-anhydromannitol for control of pH during blood storage
US5955256A (en) 1990-04-16 1999-09-21 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
ZA912842B (en) 1990-04-16 1992-03-25 Cryopharm Corp Method of inactivation of viral and bacterial blood contaminants
US5798238A (en) 1990-04-16 1998-08-25 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer
US5516629A (en) 1990-04-16 1996-05-14 Cryopharm Corporation Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5587490A (en) 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
US5545516A (en) * 1990-05-01 1996-08-13 The American National Red Cross Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light
US5232844A (en) 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5120649A (en) 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US6077659A (en) 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
US5658722A (en) 1990-05-15 1997-08-19 New York Blood Center, Inc. Process for the sterilization of biological compositions using UVA1 irradiation
DE69123569T2 (de) 1990-11-07 1997-06-05 Baxter Int Medium zur aufbewahrung von blutplättchen
DE69126861T2 (de) 1990-11-07 1998-02-26 Baxter Int Lösung zur aufbewahrung roter blutzellen
EP0525138B1 (de) 1990-12-20 1998-09-16 Baxter International Inc. Vorrichtung zum entfernen von verunreinigungen aus flüssigkeiten
US5569579A (en) 1991-04-01 1996-10-29 Thomas Jefferson University Synthetic-based platelet storage media
US5376524A (en) 1991-04-01 1994-12-27 Thomas Jefferson University Platelet storage medium containing acetate and phosphate
FR2674753B1 (fr) 1991-04-02 1995-03-10 Jean Berque Nouvelles indications therapeutiques, en particulier pour le traitement du sida, d'un medicament deja existant et fabrique a partir d'une molecule denuee de contre-indications et d'effets indesirables.
FR2715303A1 (fr) 1991-04-02 1995-07-28 Berque Jean Utilisation du FAD et/ou du NAD comme médicaments.
DE69203828T2 (de) 1991-05-08 1996-05-02 Baxter Int Verfahren zur behandlung von produkten roter blutkörperchen zur langzeitlagerung frei von mikroorganismen.
NZ244270A (en) 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
US5474891A (en) 1991-10-30 1995-12-12 Thomas Jefferson University Plasma-based platelet concentrate preparations with additive
US5234808A (en) 1991-10-30 1993-08-10 Thomas Jefferson University Acetate addition to platelets stored in plasma
US5344752A (en) 1991-10-30 1994-09-06 Thomas Jefferson University Plasma-based platelet concentrate preparations
US5247178A (en) 1991-12-12 1993-09-21 Fusion Systems Corporation Method and apparatus for treating fluids by focusing reflected light on a thin fluid layer
AU4107396A (en) 1992-03-02 1996-06-06 Cerus Corporation Synthetic media for blood components
US5288605A (en) 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
AU4677993A (en) 1992-08-07 1994-03-03 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5459030A (en) 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
US5618662A (en) 1992-03-02 1997-04-08 Cerus Corporation Intravenous administration of psoralen
SE9201413L (sv) 1992-04-30 1993-10-31 Stiftelsen Foer Medicinsk Tekn Beredning och sätt för aferesframställning av trombocytkoncentrat med väsentligt förlängd hållbarhet
US5378601A (en) 1992-07-24 1995-01-03 Montefiore Medical Center Method of preserving platelets with apyrase and an antioxidant
TW262386B (de) 1992-09-30 1995-11-11 Senju Pharma Co
US5358844A (en) 1993-02-18 1994-10-25 Brigham And Women's Hospital, Inc. Preservation of blood platelets
US5871900A (en) 1993-06-28 1999-02-16 Cerus Corporation Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens
US6004741A (en) 1993-06-28 1999-12-21 Cerus Corporation Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
US5593823A (en) 1993-06-28 1997-01-14 Cerus Corporation Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens
US5625079A (en) 1993-06-28 1997-04-29 Cerus Corporation Synthesizing psoralen compounds useful as intermediates
DE69534151T2 (de) 1994-02-22 2006-01-12 Nippon Telegraph And Telephone Corp. Gefriergetrocknete Blutzellen, Stammzellen und Plättchen und Verfahren zu deren Herstellung
FR2718353B3 (fr) 1994-04-11 1996-06-28 Jean Berque Compositions pharmaceutiques à base de produits biologiques atoxiques destinées à la protection locale des muqueuses génitales et rectales.
US5709992A (en) 1994-08-17 1998-01-20 Rubinstein; Alan I. Method for disinfecting red blood cells
US5622867A (en) 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
US5919614A (en) 1994-10-19 1999-07-06 Lifecell Corporation Composition comprising three platelet lesion inhibitors for platelet storage
EP0793414A2 (de) 1994-11-14 1997-09-10 Pall Corporation Langzeit-lagersystem für blutbestandteile und verfahren
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
JP4041171B2 (ja) * 1994-12-14 2008-01-30 日本赤十字社 血小板保存液
US5605934A (en) 1995-03-23 1997-02-25 Baxter International Inc. Method of manufacturing and storing solutions
US5624794A (en) 1995-06-05 1997-04-29 The Regents Of The University Of California Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas
US5656154A (en) 1995-06-07 1997-08-12 Organ, Inc. Method and apparatus for separating a fluid into components and for washing a material
EP0833631B1 (de) 1995-06-23 2002-11-13 Advanced Life Sciences Inc. Robustaflavon und dessen derivate als antivirales mittel
JP2930908B2 (ja) 1995-07-19 1999-08-09 川澄化学工業株式会社 血小板保存液
US5736313A (en) 1995-10-20 1998-04-07 The United States Of America As Represented By The Secretary Of The Navy Method of lyophilizing platelets by incubation with high carbohydrate concentrations and supercooling prior to freezing
US5834198A (en) 1996-03-21 1998-11-10 Boehringer Mamnnheim Gmbh Selective photoinducted flavin-dependent cleavage of RNA at G-U base pairs and kits therefor
US6060233A (en) 1996-06-14 2000-05-09 Biostore New Zealand, Ltd Methods for the lyophilization of platelets, platelet membranes or erythrocytes
US5783093A (en) 1997-01-02 1998-07-21 Haemonetics Corporation Blood cell concentrates using a single solution for anticoagulation and preservation
US6605699B1 (en) * 1997-01-21 2003-08-12 Human Genome Sciences, Inc. Galectin-11 polypeptides
EP0973383A4 (de) * 1997-01-21 2001-08-22 American Nat Red Cross Intrazelluläre und extrazelluläre dekontamination von vollblut und blutbestandteilen mit amphiphilen phenothiazin-5-ium farbstoffen und licht
US5789151A (en) 1997-05-15 1998-08-04 The Regents Of The University Of California Prolonged cold storage of red blood cells by oxygen removal and additive usage
US6063624A (en) 1997-06-09 2000-05-16 Baxter International Inc. Platelet suspensions and methods for resuspending platelets
US5922256A (en) * 1997-06-26 1999-07-13 Textron Automotive Company, Inc. Molding method for making plastic foam-backed shells
US5955257A (en) 1997-10-21 1999-09-21 Regents Of The University Of Minnesota Infusible grade short-term cell storage medium for mononuclear cells
US7094378B1 (en) * 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6268120B1 (en) * 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants

Also Published As

Publication number Publication date
EP1345491B1 (de) 2006-04-05
CA2397862C (en) 2013-04-16
CA2397862A1 (en) 2002-06-06
WO2002043485A1 (en) 2002-06-06
AU2002225687A1 (en) 2002-06-11
DE60118604D1 (de) 2006-05-18
US6548241B1 (en) 2003-04-15
DE60118604T2 (de) 2006-12-14
US20030186213A1 (en) 2003-10-02
JP4473508B2 (ja) 2010-06-02
EP1345491A1 (de) 2003-09-24
US20040023201A9 (en) 2004-02-05
JP2004514680A (ja) 2004-05-20

Similar Documents

Publication Publication Date Title
ATE322162T1 (de) Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen
DE60019473D1 (de) (S,S)-Reboxetin zur Behandlung von peripheren Neuropathien
AR035569A1 (es) Proceso y composicion para limpieza de instrumentales medicos
ATE317894T1 (de) Desinfizierendes waschen empfindlicher textilien mit persäuren
ES2160597T3 (es) Tratamiento y profilaxis de enfermedades producidas por parasitos o bacterias.
DE19882908T1 (de) Spezialbehälter zur Reinigung oder Sterilisation von Lumenvorrichtungen
ATE262336T1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
NZ334190A (en) Method for improved selectivity in photo-activation of molecular agents
EP1231914A4 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
WO2002026270A3 (en) Inactivation of contaminants using photosensitizers and pulsed light
ATE287735T1 (de) System zur desinfektion und reinigung von kontaktlinsen
ATE315558T1 (de) Verbindungen mit cytochrom p450ra1 hemmenden aktivität
DE60204584D1 (de) Zusammensetzungen enthaltend eine niedrige konzentration an peroxide zur behandlung von vaginitis
EA200400712A1 (ru) Конструкция катетера и области ее применения
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
DE60206245D1 (de) Verwendung von r-ibuprofen methanesulfonamied und dessen salzen zur behandlung und verhinderung von abstossungreaktionen in transplartierten organen
DE60110087D1 (de) Verwendung von Carboanhydrase-Inhibitoren zur Prävention von diabetischer Retinopathie bei Diabetikern
DE50105384D1 (de) Zubereitung zur behandlung von flächigen, offenen wunden
EP0605704A4 (de) Konservierung von blut, gewebe und biologischen flüssigkeiten durch stärke-iod-peroxid.
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
PT1380208E (pt) Agente desinfectante com actividade antiparasitica
ATE367824T1 (de) Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b
RU2000117703A (ru) Способ предпосевной обработки семян

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties